Speakers

Jason Acker

Professor, Laboratory Medicine and Pathology

University of Alberta, Canada

Brittany Adcock

Talent Acquisition Partner, HR Talent Strategy & Acquisition, Cell Therapy Development

Bristol Myers Squibb

Jennifer Adrian

Manager, Cellular Therapy Manufacturing Operations

bluebird bio

Joy Aho

PhD, Senior Product Manager

Be The Match BioTherapies, USA

Carlton Anderson

COO

Ambulero

Priya Baraniak

Vice President, Corporate Development

OrganaBio

Jane Barlow

MD, MPH, MBA

Jane Barlow & Associates, LLC , USA

Claudia Berrón

Senior Vice President, Business Development and Commercial Operations, BioPharma Production

Avantor

Thomas Bollenbach

Chief Technology Officer

Advanced Regenerative Manufacturing Institute

Christopher Bravery

Director

Consulting on Advanced Biologicals Ltd., Member, ISCT EU Legal and Regulatory Affairs Committee, UK

Ger Brophy

Executive Vice President, Biopharma Production

Avantor, USA

Erica Brust

Senior Process Engineer

Juno Therapeutics Inc., USA

Sonia Bulsara

Application Specialist Manager, US & Canada, Cell and Gene Therapy

Cytiva, USA

Scott Burger

Principal

Advanced Cell & Gene Therapy, USA

Phillip D. Carter

Biopharma Executive

Sylvain Cecchini

Associate Professor of Microbiology & Physiological Systems

University of Massachusetts Medical School, USA

Veeren Chauhan

Nottingham Research Fellow in Bio-inspired Therapeutics in the Advanced Materials & Healthcare Technologies

University of Nottingham

Kathryn Corzo

Head of Development Oncology Cell Therapies

Takeda

Jennifer L. Dashnau

Head of Analytical Development and Quality Control

Century Therapeutics, USA

Sumaya Dauleh

Senior Analyst

Intertek, UK

Anthony Davies, Ph.D.

Founder & CEO

Dark Horse Consulting

Lisa Deschamps

SVP, Chief Business Officer

Novartis Gene Therapies

Michael J. DiBiasio-White, Sr.

Sr. Scientist: BioProcess Development/Protein Sciences

Ring Therapeutics

David Dobnik

Scientific Associate

National Institute of Biology, Slovenia

Mehmet Dokmeci

Adjunct Professors

University of California (UCLA)

Yiyu Dong

Head Cell Line Development

WuXi Advanced Therapies, USA

Mohammed Elfar

Production Innovation Manager

Univercells Technologies

Allen Feng

Chief Scientific Officer

HebeCell Corp., USA

Miguel Forte

CEO

Bone Therapeutics, Belgium

Michael Francis

Chief Scientific Officer - Co-Founder

Embody, Faculty at EVMS

Benjamin Fryer

Founder

Pluristyx, Incorporated, USA

Chris Gemmiti, Ph.D.

SVP of Operations

Sentien Biotechnologies Inc.

Clive Glover

Director, Strategy Cell & Gene Therapy

Pall, United Kingdom

Katie Golden

Laboratory Coordinator

Vanderbilt University Medical Center, USA

Tatiana Golovina

Senior Director, Cell Therapy Process Development

WuXi Advanced Therapies, USA

Jayanthi Grebin

Senior Business Development Manager CGT

CPC - Colder Products Company, USA

Jennifer Griffin

VP Industrial Strategy & Investments

Massachusetts Life Science Center

Per Hammer

Senior Product Manager, Cell & Gene Therapy Automation and Digital solutions

Cytiva, USA

Elie Hanania

Director, Upstream Process Development

Fujifilm Diosynth, USA

Adam Haskett

Associate Director, External Manufacturing

Kite Pharma

Adam Hejmowski

Research Scientist

Pall Biotech, USA

Tony Hitchcock

Technical Director

Cobra Biologics

Geoffrey Hodge

Chief Technical Officer

Unum Therapeutics

Jeffrey Hung

Chief Commercial Officer

Vigene Biosciences, Inc., USA

Barrett J. Nehila

Associate Director, Analytical Development

Torque Therapeutics

Jan Jensen

CEO and Founder

Trailhead Biosystems Inc.

George Joseph Christ

Professor of Biomedical Engineering and Orthopaedic Surgery

University of Virginia

Sunil Karnawat

Vice President of Marketing & Sales

Ultragenyx Pharmaceutical

Nicole Kavanaugh, Ph.D

Manager, Technical Operations

Aldevron, USA

Vadim Klyushnichenko

VP Pharmaceutical Development and Quality

Calibr at Scripps Research

Jak Knowles

VP Venture Investments

Head of Pharma Investments, Leaps by Bayer

Mrignayani Kotecha

Co-Founder, CEO

O2M Technologies

Thomas Kreil

Vice President, Global Pathogen Safety

Takeda

Mani Krishnan

VP & GM Biopharma & Ce Business Unit

Sciex, USA

Kevin Lannon

Business Development – North America Cell Therapy Processing

MilliporeSigma, USA

Lisa Larkin

Professor, Molecular & Integrative Physiology Professor, Biomedical Engineering

University of Michigan, USA

Philip Lee

COO and Co-Founder

Senti Biosciences

Rachel Legmann

Director, Gene Therapy & Viral Vectors

Pall Corporation

Michael Lehmicke

Director, Science and Industry Affairs

Alliance for Regenerative Medicine

Sara Levy

CSV & Data integrity Manager

Pluristem Therapeutics Inc.

John Lewis Ph.D.

Co-founder and CEO

Aegis Life Inc. and Entos Pharmaceuticals

Joey Mason

Head of the Life Sciences Fund

M Ventures, The Netherlands

Kevin W. Mayo

Managing Partner

Venture Genome LLC

Mary Clare McCorry

Director, Technology and Process Development

Advanced Regenerative Manufacturing Institute (ARMI)

David McKenna

Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology

University of Minnesota

Ali Mohamed

VP, CMC

Immatics, USA

Mustafa Munye

Lead Scientist

Cell and Gene Therapy Catapult

Christiane Niederlaender

Director, AMBR Consulting Ltd

formerly MHRA, UK

Sarah Nikiforow

Asst. Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility

Dana-Farber Cancer Institute

Nicole Nuñez, Ph.D.,

Process Development Scientist

Eureka Therapeutics, Inc.

John O'Neill

Co-Founder & Chief Scientific Officer

Xylyx Bio, Inc.

Racheli Ofir

Vice President Research & Intellectual Property

Pluristem Therapeutics Inc., Israel

Steve Oh

Director Stem Cell Bioprocessing & Institute Professor,

Bioprocessing Technology Institute

Michelle Olson

Senior Scientist, Bioprocess R&D

Pall Biotech, USA

Thomas Parker

Process Development Scientist, Global Focal Point for Vaccines and Viral Therapies

MilliporeSigma

Philippe Parone

Director, Industrialization

Celyad, Belgium

Shyam Patel

Director Business Development

California Institute for Regenerative Medicine

Kai Pinkernell

Chief Medical Officer (CMO) & Chief Development Officer

Medigene

Supriya Pokkali

Sr. Scientist II, Research and Development Department

FUJIFULM Irvine Scientific, R&D (Cell & Gene Therapy), USA

Mathieu Porte

R&D Production Manager

Polyplus-transfection, France

Evonne R. Fearnot

Marketing Manager

Roche CustomBiotech, United States

Lior Raviv

Vice President

Pluristem Therapeutics Inc.

Betsy Rezner

Director, Process & Assay Development

Fate Therapeutics Inc.

Camillo Ricordi

Stacy Joy Goodman Professor of Surgery and Chief, Division of Cellular Transplantation, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology, Director, Diabetes Research Institute and Cell Transplant Center, University of Miami, Fellow

National Academy of Inventors, USA, Member, Italian Supreme Council of Health, USA

Andrew Rigoglioso

Associate Director, Talent Acquisition, Cell Therapy Development & Operations

Bristol Myers Squibb

Donna Rill

Chief Technology Officer

Triumvira Immunologics

Michael Roberts

Chief Technology Officer (Europe)

Asklepios BioPharmaceutical, Inc.

Jon A. Rowley, Ph.D.

Founder & Chief Product Officer

RoosterBio Inc.

Jennifer Royal-Fitch

Lead Recruiter

Gene Therapy Program & The Orphan Disease Center, Univeristy of Pennsylvania

Gregory Russotti

Chief Technology Officer

Century Therapeutics LLC, USA

Brandy Sargent

Editor

Cell Culture Dish, USA

Dominic Schmidt

Partner

Syncona Investment Management Ltd., UK

Franz Schnetzinger

Director Analytical Development

Gyroscope Therapeutics

Elizabeth Schwarzbach

CBO

New York Stem Cell Foundation

Max Sellman

Product Manager, Gene Editing

Aldevron, USA

Margarida Serra

Head of Stem Cell Bioengineering Lab

iBET - Instituto de Biologia Experimental e Tecnológica

Sha Sha

Postdoc

Massachusetts Institute of Technology

Shefali Shah

Independent Consultant

Shefali Shah Consulting, LLC

Lara Ionescu Silverman

Senior Director, Research and Development

DiscGenics

Donald Singer

Consultant

formerly, GSK Senior Fellow, Microbiology, Biopharmaceutical GMP Operations, USA

David Smith

President and Chief Commercial Officer

Akron Biotech, USA

Sarah Snykers

QC Manager

Celyad, Belgium

Scott Sobecki

Director, Research Informatics

Vanderbilt University Medical Center, USA

Lawrence Thompson, Ph.D.

Senior Principal Scientist & Group Leader

Pfizer

Nick Timmins

VP Cell Technologies and Entrepreneur in Residence

ArtisanBio, USA

Hartmut Tintrup

Global Head of Business Development for CGT

Lonza Pharma & Biotech

Steve Tottey

Associate Director, Downstream Process Development

WuXi Advanced Therapies, USA

Tracy TreDenick-Fricke

Head of Regulatory and Quality

BioTechLogic, USA

Jesse Trekker

Business Manager

Catalent Cell and Gene Therapy, Belgium

Sowmya Viswanathan

Scientist

University Health Network, Canada

Sam Wadsworth

Chief Scientific Officer

Ultragenyx Gene Therapy

Tom Walls

Global Planning and Logistics Lead

Spark Therapeutics, USA

Kathy Williams

VP of Quality and Reg Affairs

RoosterBio, Inc., USA

Rachel Yost

Senior Process Engineer

Juno Therapeutics Inc.

Frank Zhang

Head of Market Access

uniQure

Mike Zhao

Senior Vice President

MSQ Ventures

Qin Zou, Ph.D.

Associate Research Fellow and Group Leader

Pfizer

Claudia Zylberberg

CEO

Akron Biotech

Aleš Štrancar

CEO

BIA Separations, Slovenia